BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[The Timely Ten: Blue Chip Dividends]]>http://www.bloggingstocks.com/2011/03/30/the-timely-ten-blue-chip-dividends/http://www.bloggingstocks.com/2011/03/30/the-timely-ten-blue-chip-dividends/http://www.bloggingstocks.com/2011/03/30/the-timely-ten-blue-chip-dividends/#commentsFiled under: , , , , , , , , ,

Procter and Gamble (PG) logo"Our goal is helping investors grow their capital and income base from which to derive cash for their current and future needs," notes dividend expert Kelley Wright.

The editor of Investment Quality Trends explains, "To that end we believe that high-quality stocks purchased at historically low-price-to-high-yield offers the best potential for downside protection and upside appreciation. Our Timely Ten list represents our current top ideas.

Continue reading The Timely Ten: Blue Chip Dividends

The Timely Ten: Blue Chip Dividends originally appeared on BloggingStocks on Wed, 30 Mar 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott LabsabtAttblue chip stocksCoca-Coladividend stocksexcExelonfeaturedhdHome DepotIncomeInvestmentQualityTrendsiq trendsjnjJohnsonJohnsonkelley wrightKoMolsonCoorsPepPepsiCopgProcter Gamblesteven halpernttapthestockadvisors.comUnitedTechnologiesutxyieldWed, 30 Mar 2011 10:00:00 EST<![CDATA[A 'Fool-Proof' Retirement Plan for 20-Year-Olds]]>http://www.bloggingstocks.com/2011/03/07/a-fool-proof-retirement-plan-for-20-year-olds/http://www.bloggingstocks.com/2011/03/07/a-fool-proof-retirement-plan-for-20-year-olds/http://www.bloggingstocks.com/2011/03/07/a-fool-proof-retirement-plan-for-20-year-olds/#commentsFiled under: , , ,

"I've put together a retirement blue print that will allow anyone who is 20 years old or younger to retire a multi-millionaire," says Steve Christ.

The editor of The Wealth Advisory explains, "This diversified portfolio, contains a transport, a utility, a tech company, a health care giant, and a defense contractor, all of which pay nice steady dividends with room for growth.

"All you need to start is $15,000 initial investment to go along with an additional $100 bucks a week in total contributions divided among the five stocks.

Continue reading A 'Fool-Proof' Retirement Plan for 20-Year-Olds

A 'Fool-Proof' Retirement Plan for 20-Year-Olds originally appeared on BloggingStocks on Mon, 07 Mar 2011 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott Laboratoriesabtdukduke energyfeaturedintcIntelLMTNorfolkSouthernnscretirement portfoliosteve christsteven halpernStevenHalpernthestockadvisors.comwealth advisoryMon, 07 Mar 2011 11:00:00 EST<![CDATA[Abbott (ABT) and Baxter (BAX): Healthy Gains]]>http://www.bloggingstocks.com/2011/03/01/abbott-abt-and-baxter-bax-healthy-gains/http://www.bloggingstocks.com/2011/03/01/abbott-abt-and-baxter-bax-healthy-gains/http://www.bloggingstocks.com/2011/03/01/abbott-abt-and-baxter-bax-healthy-gains/#commentsFiled under: , , ,

"We follow an approach to investng that focuses on broadly diversified investments in undervalued stocks for their long-term appreciation potential," says value investor John Buckingham.

The money manager and editor of The Prudent Speculator explains, " Two recently featured ideas -- Abbott Laboratories (ABT) and Baxter International (BAX) -- are among those we feel could serve as a portfolio foundation or as a new ideas for well- diversified holdings.

Continue reading Abbott (ABT) and Baxter (BAX): Healthy Gains

Abbott (ABT) and Baxter (BAX): Healthy Gains originally appeared on BloggingStocks on Tue, 01 Mar 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott LaboratoriesabtBaxbaxter internationalBaxterInternationaldrug stocksDrugStocksfeaturedhealthcare stocksjohn buckinghamprudent speculatorPrudentSpeculatorsteven halpernthestokadvisors.comTue, 01 Mar 2011 10:00:00 EST<![CDATA[The Timely 10: Best Blue Chip Dividend Buys]]>http://www.bloggingstocks.com/2011/01/28/the-timely-10-iq-trends-best-blue-chip-buys/http://www.bloggingstocks.com/2011/01/28/the-timely-10-iq-trends-best-blue-chip-buys/http://www.bloggingstocks.com/2011/01/28/the-timely-10-iq-trends-best-blue-chip-buys/#commentsFiled under: , , , , , , , , , , , ,

AT&T logo"High-quality stocks bought at historically low-price-to-high-yield offer the best potential for downside protection and upside appreciation," says dividend specialist Kelley Wright.

The editor of IQ Trends explains, "Our 'Timely Ten' list is our reasoned expectation based on our methodology and experience for what we believe will perform best over the next five years.

"Our 'Timely Ten' list is our reasoned expectation based on our methodology and experience for what we believe will perform best over the next five years. Do we believe that all 10 will go up simultaneously or immediately? Of course not.

Continue reading The Timely 10: Best Blue Chip Dividend Buys

The Timely 10: Best Blue Chip Dividend Buys originally appeared on BloggingStocks on Fri, 28 Jan 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott Laboratoriesabtaltria groupattblue chip stockscoca-coladividend stocksEXCExelonfeaturedincome stocksinvestment quality trendsiq trendsjnjjohnson and johnsonkelley wrightkomomolson coorspepPepsicopgprocter and gamblesteven halperntapthestockadvisors.comunited technologiesutxyield stocksFri, 28 Jan 2011 10:00:00 EST<![CDATA[A Growth and Income Trio for All Investors]]>http://www.bloggingstocks.com/2011/01/17/a-growth-and-income-trio-for-all-investors/http://www.bloggingstocks.com/2011/01/17/a-growth-and-income-trio-for-all-investors/http://www.bloggingstocks.com/2011/01/17/a-growth-and-income-trio-for-all-investors/#commentsFiled under: , , ,

growth and income"It seems plausible to expect the index to return about 13% in the coming year; not exactly a runaway bull, but a bright enough prospect to keep us in the game," says blue chip expert Richard Band.

The editor of Profitable Investing explains, "Here are three growth-and-income names that I deem suitable for virtually all investors of any age: Abbott Laboratories (ABT), Sysco (SYY) and Time Warner (TWX).

"Whether you're three years or 33 years from retirement, now is a good time to stock up on this trio of growth and income recommendations.

Continue reading A Growth and Income Trio for All Investors

A Growth and Income Trio for All Investors originally appeared on BloggingStocks on Mon, 17 Jan 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott Labsabtdividendsfeaturedgrowth income stocksincomeprofitable investingrichard bandsteven halpernsyscoSYYthestockadvisors.comtime warnertwxMon, 17 Jan 2011 10:00:00 EST<![CDATA[Abbott Labs (ABT): A Rich Pipeline in Pharma]]>http://www.bloggingstocks.com/2010/12/01/abbott-labs-abt-a-rich-pipeline-in-pharma/http://www.bloggingstocks.com/2010/12/01/abbott-labs-abt-a-rich-pipeline-in-pharma/http://www.bloggingstocks.com/2010/12/01/abbott-labs-abt-a-rich-pipeline-in-pharma/#comments"Because major U.S. pharmaceutical companies face patent expirations on blockbuster drugs, consensus earnings expectations for the group are modest," says Richard Moroney.

The editor of Dow Theory Forecasts explains, "One exception is Abbott Laboratories (ABT); Wall Street expects to increase earnings at a 10% annual rate over the next five years.

"Yet the market appears to discount that outlook, and the stock's price/earnings-to-growth ratio (PEG) of 1.2 is well below its peers.

Continue reading Abbott Labs (ABT): A Rich Pipeline in Pharma

Abbott Labs (ABT): A Rich Pipeline in Pharma originally appeared on BloggingStocks on Wed, 01 Dec 2010 10:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abbottAbbott Laboratoriesabtdow theory forecastsdrug stocksfeaturedhealthcare stockshumirapharma stockspharmaceutical stocksrichard moroneythestockadvisors.comWed, 01 Dec 2010 10:20:00 EST<![CDATA[Analyst Calls: ABT, ALU, CSCO, EL, F, KKR, QCOM, RIMM, SAP, STP, TIVO ...]]>http://www.bloggingstocks.com/2010/11/18/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/11/18/analyst-upgrades-downgrades/http://www.bloggingstocks.com/2010/11/18/analyst-upgrades-downgrades/#commentsFiled under: , , , , , , , , ,

Analyst Upgrades

  • Qualcomm (QCOM) was upgraded to outperform from neutral at Credit Suisse.
  • JPMorgan upgraded Allegheny Tech (ATI) to overweight from neutral.
  • NetApp (NTAP) was upgraded to buy from hold at Canaccord.
  • Estee Lauder (EL) was upgraded to perform from underperform at Oppenheimer.
  • Citigroup upgraded Suntech (STP) to hold from sell.

Continue reading Analyst Calls: ABT, ALU, CSCO, EL, F, KKR, QCOM, RIMM, SAP, STP, TIVO ...

Analyst Calls: ABT, ALU, CSCO, EL, F, KKR, QCOM, RIMM, SAP, STP, TIVO ... originally appeared on BloggingStocks on Thu, 18 Nov 2010 11:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott LabsABTAlcatel-LucentALUanalyst upgradesATIBSPMCiscoCSCOdowngradesELEstee LauderFFordGMRinitiationsinthenewsKKRLOGILogitechNetApNPDNTAPQCOMQualcomResearch In MotionRIMMSAPSLRCSTPSuntecTIVOThu, 18 Nov 2010 11:20:00 EST<![CDATA[Graham/Buffett Buys: A Six-Pack of Values]]>http://www.bloggingstocks.com/2010/09/20/graham-buffett-buys-a-six-pack-of-values/http://www.bloggingstocks.com/2010/09/20/graham-buffett-buys-a-six-pack-of-values/http://www.bloggingstocks.com/2010/09/20/graham-buffett-buys-a-six-pack-of-values/#commentsFiled under: , , ,

Warren Buffett"Benjamin Graham has been recognized for decades as the father of value investing; Warren Buffett is known as the Oracle of Omaha for his superior investing skills," asserts J. Royden Ward, adding, "For this report, we combine Warren Buffett's and Ben Graham's criteria for choosing stocks.

The advisor reviews Abbott Laboratories (ABT), Coach (COH), Intel (INTC), Mastercard (MA), Microsoft (MSFT) and Tupperware Brands (TUP).

Continue reading Graham/Buffett Buys: A Six-Pack of Values

Graham/Buffett Buys: A Six-Pack of Values originally appeared on BloggingStocks on Mon, 20 Sep 2010 10:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abbot laboratoriesabtben grahamcabot benjamin graham value lettercoachfeaturedintcintelj. royden wardmamicrosoftsteven halpernthestockadvisors.comtupvalue investingvalues stockswarren buffettMon, 20 Sep 2010 10:30:00 EST<![CDATA[Blue Chip Trio: IBM, Abbott and Automated Data]]>http://www.bloggingstocks.com/2010/08/26/blue-chips-ibm-abbott-adp/http://www.bloggingstocks.com/2010/08/26/blue-chips-ibm-abbott-adp/http://www.bloggingstocks.com/2010/08/26/blue-chips-ibm-abbott-adp/#commentsFiled under: , ,

ADP logo"We believe that high-quality stocks purchased at historically low-price-to-high-yield offers the best potential for downside protection and upside appreciation," says dividend specialist Kelley Wright.

The editor of Investment Quality Trends explains, "Here we look at three blue chip stocks that have earned our top designation for outstanding dividend growth: IBM (IBM), Automated Data Processing (ADP) and Abbott Laboratories (ABT).

Continue reading Blue Chip Trio: IBM, Abbott and Automated Data

Blue Chip Trio: IBM, Abbott and Automated Data originally appeared on BloggingStocks on Thu, 26 Aug 2010 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abtADPblue chip stocksdividend investingfeaturedibmincome investinginternational business machinesinvestment quality trendsiq trendskelley wrightsteven halpernthestockadvisors.comyield investingThu, 26 Aug 2010 11:00:00 EST<![CDATA[Blue Chip Buys: The Timely Ten]]>http://www.bloggingstocks.com/2010/07/14/blue-chip-buys-the-timely-ten/http://www.bloggingstocks.com/2010/07/14/blue-chip-buys-the-timely-ten/http://www.bloggingstocks.com/2010/07/14/blue-chip-buys-the-timely-ten/#commentsKelley Wright.

The editor of Investment Quality Trends explains, "To that end we believe that high-quality stocks purchased at historically low-price-to-high-yield offers the best potential for downside protection and upside appreciation.

"The Timely Ten list of stocks is our reasoned expectation based on our methodology and experience for what we believe will perform best over the next five years.

Continue reading Blue Chip Buys: The Timely Ten

Blue Chip Buys: The Timely Ten originally appeared on BloggingStocks on Wed, 14 Jul 2010 13:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott Laboratoriesabtadpautomatic data processingblue chip stockscoca-colacvxdividendsExxonMobilincome stocksinvestment quality trendsiq trendsjnjjohnson and johnsonkomcdmcdonaldspeppgpmprocter and gamblesteven halpernthestockadvisors.comxomyield stocksWed, 14 Jul 2010 13:20:00 EST<![CDATA[Analyst Calls: AAPL, ABT, AMZN, BMY, CSCO, DNB, EAT, INTU, NILE ...]]>http://www.bloggingstocks.com/2010/06/07/analyst-calls/http://www.bloggingstocks.com/2010/06/07/analyst-calls/http://www.bloggingstocks.com/2010/06/07/analyst-calls/#commentsFiled under: , , , , , , ,

Analyst Upgrades

  • Auriga upgraded Cisco (CSCO) to buy from hold, citing the company's improving strategic position in data centers.
  • Blue Nile (NILE) was raised to buy from hold by Citigroup due to the recent pullback in shares.
  • DuPont Fabros (DFT) was upgraded to buy from neutral at UBS, which said that said fundamentals in the data center space have been improving.
  • Baird upgraded Sterling Bancshares (SBIB) to neutral from underperform based on valuation.
  • Goldman Sachs upgraded Bristol-Myers (BMY) to buy from neutral.
  • Amazon.com (AMZN) was raised to conviction buy from buy by Goldman.
  • Jefferies upgraded Celgene (CELG) to buy from hold.

Continue reading Analyst Calls: AAPL, ABT, AMZN, BMY, CSCO, DNB, EAT, INTU, NILE ...

Analyst Calls: AAPL, ABT, AMZN, BMY, CSCO, DNB, EAT, INTU, NILE ... originally appeared on BloggingStocks on Mon, 07 Jun 2010 11:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AAPLABTAmazon.comAMZNanalyst upgradesAppleBMYCELGCHSCiscoCSCODFTDNBdowngradesEATEXLFSLRinitiationsinthenewsINTULRYNILERRGBSBIBSPWRASTPWPRTMon, 07 Jun 2010 11:20:00 EST<![CDATA[Analyst Calls: ABT, AON, APA, BX, CSIQ, FSLR, GRMN, GXDX, PCLN, RIG, XOM ...]]>http://www.bloggingstocks.com/2010/05/24/analyst-calls-abt-aon-apa-bx-fslr-grmn-pcln-rig-xom/http://www.bloggingstocks.com/2010/05/24/analyst-calls-abt-aon-apa-bx-fslr-grmn-pcln-rig-xom/http://www.bloggingstocks.com/2010/05/24/analyst-calls-abt-aon-apa-bx-fslr-grmn-pcln-rig-xom/#commentsFiled under: , ,

Analyst Upgrades

  • FBR Capital upgraded Transocean (RIG) to outperform from market perform as it believes congressional hearings and reports indicate the company's blowout preventer at the Deepwater Horizon likely worked properly. The firm has an $87 price target for shares.
  • Auriga upgraded First Solar (FSLR) to buy from hold as it believes the recent sell-off in shares as created an attractive entry point. Despite upgrading, the firm lowered its target for shares to $138 from $147.
  • Soleil upgraded Priceline.com (PCLN) to buy from hold, citing a favorable risk-reward profile. Despite the upgrade, the firm lowered its target for shares to $230 from $250.
  • Blackrock (BLK) was upgraded to conviction buy from buy at Goldman.
  • Abbott (ABT) was upgraded to hold from sell at Citigroup.
  • Exxon Mobil (XOM) was upgraded to outperform from sector perform at RBC Capital.

Continue reading Analyst Calls: ABT, AON, APA, BX, CSIQ, FSLR, GRMN, GXDX, PCLN, RIG, XOM ...

Analyst Calls: ABT, AON, APA, BX, CSIQ, FSLR, GRMN, GXDX, PCLN, RIG, XOM ... originally appeared on BloggingStocks on Mon, 24 May 2010 11:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ABTACFNAMBanalyst upgradesAONAPABlackrockBlackstoneBLKBXCNWCREECSIQdowngradesFSLRGarminGRMNGXDXinitiationsinthenewsPCLNRCRCRIGVMEDXOMMon, 24 May 2010 11:30:00 EST<![CDATA[IQ Trends' Blue Chip Buys: The 'Timely Ten']]>http://www.bloggingstocks.com/2010/04/23/iq-trends-the-timely-ten-for-blue-chip-buys/http://www.bloggingstocks.com/2010/04/23/iq-trends-the-timely-ten-for-blue-chip-buys/http://www.bloggingstocks.com/2010/04/23/iq-trends-the-timely-ten-for-blue-chip-buys/#commentsFiled under: , , , , , , , ,

"Our primary purpose at Investment Quality Trends is to assist investors in growing their capital and income base from which to derive cash for their current and future needs," says Kelley Wright.

The editor of IQ Trends explains, "To that end we believe that high-quality stocks purchased at historically low-price-to-high-yield offers the best potential for downside protection and upside appreciation.

Continue reading IQ Trends' Blue Chip Buys: The 'Timely Ten'

IQ Trends' Blue Chip Buys: The 'Timely Ten' originally appeared on BloggingStocks on Fri, 23 Apr 2010 13:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abbot labsabtadpautomatic datablue chip stockschevroncloroxcoca-coladividend stocksinvestment quality trendsiq trendskelley wrightkoomniconpepsicopgprocter gamblesteven halpernthestockadvisors.comtimely tenunited technolgiesutswal martwmtFri, 23 Apr 2010 13:00:00 EST<![CDATA[AstraZeneca and Abbott Labs Receive FDA Response]]>http://www.bloggingstocks.com/2010/03/30/astrazeneca-and-abbott-labs-receive-fda-response/http://www.bloggingstocks.com/2010/03/30/astrazeneca-and-abbott-labs-receive-fda-response/http://www.bloggingstocks.com/2010/03/30/astrazeneca-and-abbott-labs-receive-fda-response/#commentsFiled under:

AstraZeneca (AZN) and Abbott Laboratories (ABT) announced this morning they received a complete response letter from the Food and Drug Administration regarding their new drug application for Certriad capsules. The FDA requested more information. The companies stated that they are currently evaluating the FDA's letter and will continue discussions with the agency to see what the next step will be with the drug. AZN and ABT will then respond to the FDA's request for further information.

Certriad is for the treatment of mixed dyslipidemia, a combination of two or more lipid abnormalities including the "bad" cholesterol (LDL), high triglycerides, and low "good" cholesterol (HDL). The active ingredients in Certirad are Crestor and Trilipix from ABT and AZN.

Continue reading AstraZeneca and Abbott Labs Receive FDA Response

AstraZeneca and Abbott Labs Receive FDA Response originally appeared on BloggingStocks on Tue, 30 Mar 2010 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott LaboratoriesABTAstraZenecaazncholesterolcholesterol drugsFDAfeaturedinthenewsTue, 30 Mar 2010 10:00:00 EST<![CDATA[Analyst Calls: ABT, ARO, BMY, CELG, DNDN, FACT, GS, PSUN, SCCO, ULTI ...]]>http://www.bloggingstocks.com/2010/03/12/analyst-calls/http://www.bloggingstocks.com/2010/03/12/analyst-calls/http://www.bloggingstocks.com/2010/03/12/analyst-calls/#commentsFiled under: , , , , , ,

Analyst Upgrades

  • Deutsche Bank upgraded Southern Copper (SCCO) to buy from hold to reflect valuation and positive near-term catalysts. The firm raised its target for shares to $38 from $35.
  • JMP Securities upgraded Ultimate Software (ULTI) to outperform from market perform. The firm cites the company's expanding employee base for the upgrade. The firm has a $40 target on the stock.
  • Piper Jaffray upgraded Aeropostale (ARO) to neutral from underweight following the company's Q4 results and raised its target for shares to $31 from $24.
  • Kennametal (KMT) was upgraded to sell from conviction sell at Goldman.
  • Lifetime Brands (LCUT) was upgraded to outperform from market perform at Barrington.
  • Volvo (VOLVY) was upgraded to overweight from underweight at JPMorgan.

Continue reading Analyst Calls: ABT, ARO, BMY, CELG, DNDN, FACT, GS, PSUN, SCCO, ULTI ...

Analyst Calls: ABT, ARO, BMY, CELG, DNDN, FACT, GS, PSUN, SCCO, ULTI ... originally appeared on BloggingStocks on Fri, 12 Mar 2010 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AbbottAbbott LaboratoriesAbbott LabsABTAeropostaleAROBMYBristol MyersCELGCelgeneClearwater PaperCLWDendreonDNDNdowngradesFacet BiotechFACTGILDGileadGoldman SachsGrand CanyonGSHBCHSBCHSBC HoldingsinitiationsinthenewsKennametalKMTLCUTLifetime BrandsLOPENRGNRG EnergyPacific SunwearProvengePSUNSCCOSGISilicon GraphicsSouthern CopperULTIUltimate SoftwareVolvoVOLVYFri, 12 Mar 2010 11:00:00 EST<![CDATA[Abbott Labs to Acquire Facet Biotech]]>http://www.bloggingstocks.com/2010/03/10/abbot-labs-to-acquire-facet-biotech/http://www.bloggingstocks.com/2010/03/10/abbot-labs-to-acquire-facet-biotech/http://www.bloggingstocks.com/2010/03/10/abbot-labs-to-acquire-facet-biotech/#commentsFiled under: ,

After the closing bell Tuesday, Abbott Laboratories (ABT) announced that it will acquire Facet Biotech (FACT) for $27 per share. The transaction carries a total price tag of $722 million. Including $272 million of FACT's cash and securities, the net cost turns out to be roughly $450 million.

Back in December, FACT turned down Biogen Idec's (BIIB) unsolicited takeover offer of $17.50 per share. The deal is expected to close in the second quarter, as both boards of directors have approved the deal.

Continue reading Abbott Labs to Acquire Facet Biotech

Abbott Labs to Acquire Facet Biotech originally appeared on BloggingStocks on Wed, 10 Mar 2010 08:50:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Abbott LabsabtacquisitionacquisitionsbiibBiogen IdecFacet BiotechfactfeaturedinthenewsWed, 10 Mar 2010 08:50:00 EST<![CDATA[Quality Yields: IQ Trend's Timely Ten]]>http://www.bloggingstocks.com/2010/02/11/quality-yields-iq-trends-timely-ten/http://www.bloggingstocks.com/2010/02/11/quality-yields-iq-trends-timely-ten/http://www.bloggingstocks.com/2010/02/11/quality-yields-iq-trends-timely-ten/#commentsFiled under: , , , , , ,

"Our primary purpose is to assist investors in growing their capital and income base from which to derive cash for their current and future needs," says Kelley Wright.

The editor of IQ Trends -- and author of the just-released book Dividends Still Don't Lie -- explains, "To that end we believe that high-quality stocks purchased at historically low-price-to-high-yield offers the best potential for downside protection and upside appreciation.

Continue reading Quality Yields: IQ Trend's Timely Ten

Quality Yields: IQ Trend's Timely Ten originally appeared on BloggingStocks on Thu, 11 Feb 2010 10:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abbott labsabtautomatic data processingblue chip stockschevroncloroxclxcoca-colacvxdividend stocksincome stocksinvestment quality trendsiq trendskelley wrightkomcdmcdonaldsmolson coorsMolsonCoorspeppepsicopgphillip morris internationalpmprocter gamblesteven halpernStevenHalperntapthestockadvisors.comThu, 11 Feb 2010 10:30:00 EST<![CDATA[Serious Money: Cheapest Stocks Yet -- From 35 to 26]]>http://www.bloggingstocks.com/2010/02/03/serious-money-cheapest-stocks-yet-from-35-to-26/http://www.bloggingstocks.com/2010/02/03/serious-money-cheapest-stocks-yet-from-35-to-26/http://www.bloggingstocks.com/2010/02/03/serious-money-cheapest-stocks-yet-from-35-to-26/#commentsFiled under: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Is the market overpriced? Maybe it is cheap, or perhaps it is fairly valued. This is the third in a series examining the issue. Still, it has been my contention that it does not make any difference because no matter how the market is valued as a whole, there are plenty of cheap stocks out there to accommodate a large amount of capital allocation even this deep into a bull run.

If you would like to follow along from the beginning, the initial post screened stocks for lower than market average P/E ratios: Serious Money: Market Looks Cheap to Me -- 35 Stocks. In the second installment, I looked at yield and PEG ratios: Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth.

Continue reading Serious Money: Cheapest Stocks Yet -- From 35 to 26

Serious Money: Cheapest Stocks Yet -- From 35 to 26 originally appeared on BloggingStocks on Wed, 03 Feb 2010 10:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abtadmazobmycbcopcpbcvxdddriebayezpwfeaturedgisgshasibmjnjjpmkmblmtmrkpfertnserious moneySeriousMoneystock screensStockScreenstrvvzwmtxelWed, 03 Feb 2010 10:40:00 EST<![CDATA[Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth]]>http://www.bloggingstocks.com/2010/02/01/serious-money-still-cheap-market-35-stocks-yields-and-growth/http://www.bloggingstocks.com/2010/02/01/serious-money-still-cheap-market-35-stocks-yields-and-growth/http://www.bloggingstocks.com/2010/02/01/serious-money-still-cheap-market-35-stocks-yields-and-growth/#commentsFiled under: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Let's try and reduce the gambling by examining the facts and ignoring what the bulls and bears are chatting up at the moment. We started the process by screening for lower than market average P/E ratios, see: Serious Money: Market Looks Cheap to Me -- 35 Stocks.

Two more important criteria influence today's review: the yield, a favorite of "my pal Warren"; and the price-to-earnings-to-growth (PEG) a focus of Peter Lynch, the retired fund manager extraordinaire of Fidelity's Magellan Fund.

Continue reading Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth

Serious Money: Still Cheap Market -- 35 Stocks + Yields & Growth originally appeared on BloggingStocks on Mon, 01 Feb 2010 14:50:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abtadmaepaflazobmycbcopcpbcvscvxdddriebayezpwfeaturedgisgshashpqibmjnjjpmkmblmtmomrknepfertnserious moneySeriousMoneysheldon liberSheldonLiberstock screensstocks to buyStockScreensStocksToBuysyytvrunhvzwmtxelMon, 01 Feb 2010 14:50:00 EST<![CDATA[Serious Money: Market Looks Cheap to Me -- 35 Stocks]]>http://www.bloggingstocks.com/2010/01/28/serious-money-market-looks-cheap-to-me-35-stocks/http://www.bloggingstocks.com/2010/01/28/serious-money-market-looks-cheap-to-me-35-stocks/http://www.bloggingstocks.com/2010/01/28/serious-money-market-looks-cheap-to-me-35-stocks/#commentsFiled under: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

We frequently receive comments that the market is overpriced. Recently one of our active readers commented that the market P/E was 30, which it's not. The actual rate (S&P forecast) has been even higher at times due to the volatile market.

The average should trend closer to the long term P/E of 15.7 in the next few years. However, I have reviewed companies often covered on our site and come up with a list of 35 stocks that have price-to-earning ratios below the long-term average already. I think there are dozens of bargains regardless of the status of the overall market.

Continue reading Serious Money: Market Looks Cheap to Me -- 35 Stocks

Serious Money: Market Looks Cheap to Me -- 35 Stocks originally appeared on BloggingStocks on Thu, 28 Jan 2010 15:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ABTADMAFLBMYCBCoPCPBCVSCVXDDDRIebayEZPWfeaturedGISGSHASHPQIBMJNJJPMKMBLMTMoMRKpfeserious moneySeriousMoneysheldon liberSheldonLiberTRVWMTXELThu, 28 Jan 2010 15:00:00 EST